38 Stocks Moving In Thursday's Mid-Day Session

Gainers

Check out these big penny stock gainers and losers

Losers

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.

Posted In:

News Penny Stocks Small Cap Intraday Update Markets Movers Trading Ideas Mid-Day Movers Top Gainers

Gainers

Newegg Commerce Inc. (NASDAQ:NEGG) shares jumped 30% to $12.03.
Precipio, Inc. (NASDAQ:PRPO) gained 22.3% to $5.05. Precipio recently announced it launched a new, four-hour Acute Myeloid Leukemia HemeScreen panel to specifically determine the genetics of this aggressive, acute form of leukemia.
BBQ Holdings, Inc. (NASDAQ:BBQ) surged 21.5% to $14.88 after the company reported a rise in quarterly sales.
InnSuites Hospitality Trust (NYSE:IHT) shares jumped 19.8% to $6.29 after dropping 11% on Wednesday. The company recently reported 2021 sales of $4.20 million versus $6.57 million year over year.
PDS Biotechnology Corporation (NASDAQ:PDSB) rose 18.3% to $6.79 after the company announced the publication of an abstract by the American Society of Clinical Oncology summarizing interim data from the National Cancer Institute (NCI)-led Phase 2 trial evaluating a combination of PDS0101, M9241, and bintrafusp alfa in patients with HPV 16+ relapsed or refractory advanced cancer.
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) gained 18.3% to $19.31. Iovance Biotherapeutics recently provided a regulatory update for lifileucel potency assays. Following the update, the company CEO resigned.
Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) rose 16.7% to $11.35. Sensei Biotherapeutics revealed new data from the ongoing Phase 1/2 clinical trial of SNS-301 in patients with advanced squamous cell carcinoma of the head and neck (SCCHN), in combination with pembrolizumab.
F-star Therapeutics, Inc. (NASDAQ:FSTX) gained 15.2% to $7.98. HC Wainwright & Co. recently initiated coverage on the stock with a Buy rating and a price target of $35 per share.
Immutep Limited (NASDAQ:IMMP) rose 14.2% to $4.69 after the company announced the publication of TACTI-002 and INSIGHT-004 abstracts for ASCO 2021 Annual Meeting.
Nam Tai Property Inc. (NYSE:NTP) surged 14.1% to $22.91.
Youdao, Inc. (NYSE:DAO) shares jumped 14% to $25.54 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and announced a price target of $30 per share.
Summit Wireless Technologies, Inc. (NASDAQ:WISA) gained 13.6% to $4.625. The company, last week, released quarterly results.
Lightspeed POS Inc. (NYSE:LSPD) jumped 13% to $64.88 after reporting Q4 results.
Genetron Holdings Limited (NASDAQ:GTH) gained 12.7% to $21.89 after the company reported a strategic partnership with JD Health to create innovative solutions for full-cycle cancer management.
VistaGen Therapeutics, Inc (NASDAQ:VTGN) shares rose 12.2% to $2.5801. Baird initiated coverage on the stock with an Outperform rating and a $9 price target.
Vera Therapeutics, Inc. (NASDAQ:VERA) jumped 11.6% to $17.13. Vera Therapeutics, last week, priced its 4.35 million share IPO at $11 per share, well below its targeted range of $14 to $16, raising $47.58 million in gross proceeds.
MoSys, Inc. (NASDAQ:MOSY) gained 9.5% to $5.98 after jumping 44% on Wednesday.
Adaptimmune Therapeutics plc (NASDAQ:ADAP)shares rose 9.5% to $5.36 after the company revealed initial data from its Phase 2 SPEARHEAD-1 trial evaluating afamitresgene autoleucel (afami-cel, formerly ADP-A2M4).
SG Blocks, Inc. (NASDAQ:SGBX) shares rose 9% to $3.3683 after the company issued strong sales guidance for the first quarter.
DarioHealth Corp. (NASDAQ:DRIO) gained 7.8% to $16.82. DarioHealth recently reported a Q1 net loss of $15 million and agreed to acquire PsyInnovations Inc (dba wayForward), a behavioral health digital platform, for $30 million.
Super League Gaming, Inc. (NASDAQ:SLGG) rose 7.1% to $4.67. Super League Gaming recently reported a Q1 loss of $0.21 per share.
Advaxis, Inc. (NASDAQ:ADXS) shares rose 6% to $0.6098 after the company announced updated data from its Phase 1/2 study evaluating ADXS-503 in combination with Merck & Co Inc's Keytruda (pembrolizumab) in patients with metastatic non-small-cell lung cancer (NSCLC)..
PolarityTE, Inc. (NASDAQ:PTE) rose 5.7% to $1.0350 after a Form4 filing showed insider Peter A Cohen bought 265,000 shares of common stock at $0.98 per share for a total cost of $259,382.
ObsEva SA (NASDAQ:OBSV) rose 5% to $2.97 after the company announced final 76-week results from the PRIMROSE 1 Phase 3 clinical study evaluating Yselty (linzagolix) for heavy menstrual bleeding due to uterine fibroids.

Check out these big penny stock gainers and losers

Losers

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) shares dipped 30.3% to $15.49 after the company reported initial data from the Phase 1 dose-escalation portion of the Phase 1/2 MasterKey-01 trial evaluating BDTX-189 in patients with advanced solid tumors.
Merus N.V. (NASDAQ:MRUS) shares declined 16.7% to $21.00. Merus reported publication of abstract on Zenocutuzumab in NRG1-fusion (NRG1+) cancers at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting.
Aerpio Pharmaceuticals, Inc. (NASDAQ:ARPO) dropped 15.8% to $1.8699. The company issued an update on Aadi Bioscience presentation at the ASCO 2021 virtual meeting.
Omeros Corporation (NASDAQ:OMER) tumbled 13% to $14.77 after the company revealed that the FDA needs additional time to review narsoplimab marketing application for hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA).
Lordstown Motors Corp. (NASDAQ:RIDE) fell 12.6% to $10.01 after Wolfe Research downgraded the stock from Peer Perform to Underperform and lowered its price target from $18 to $1.
Kohl's Corporation (NYSE:KSS) dropped 12.3% to $52.85 despite the company better-than-expected Q1 results and raised FY21 outlook.
Triumph Group, Inc. (NYSE:TGI) fell 11.7% to $14.53 following Q4 results.
HOOKIPA Pharma Inc. (NASDAQ:HOOK) fell 11.4% to $16.86. HOOKIPA will present Phase 1 safety, tolerability and preliminary anti-tumor activity data on Hb-201 And Hb-202 for the treatment of advanced Hpv16+ cancers at the ASCO.
Fossil Group, Inc. (NASDAQ:FOSL) dipped 10.7% to $11.83.
Barnwell Industries, Inc. (NYSE:BRN) fell 9.6% to $2.645. The company, last week, reported quarterly results.
Ralph Lauren Corporation (NYSE:RL) dropped 9% to $119.22. Ralph Lauren swung to a profit in the fourth quarter.
Abercrombie & Fitch Co. (NYSE:ANF) fell 7.7% to $37.42.
FutureFuel Corp. (NYSE:FF) shares fell 6.6% to $12.55. FutureFuel, earlier during the month, reported Q1 results.
Wunong Net Technology Company Limited (NASDAQ:WNW) fell 6.5% to $6.97 after the company received notice of non-compliance with Nasdaq related to delayed filing of Form 20-F for FY20 period.

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.

Posted In:

News Penny Stocks Small Cap Intraday Update Markets Movers Trading Ideas Mid-Day Movers Top Gainers

Comments

Newegg Commerce Inc. (NASDAQ:NEGG) shares jumped 30% to $12.03.
Precipio, Inc. (NASDAQ:PRPO) gained 22.3% to $5.05. Precipio recently announced it launched a new, four-hour Acute Myeloid Leukemia HemeScreen panel to specifically determine the genetics of this aggressive, acute form of leukemia.
BBQ Holdings, Inc. (NASDAQ:BBQ) surged 21.5% to $14.88 after the company reported a rise in quarterly sales.
InnSuites Hospitality Trust (NYSE:IHT) shares jumped 19.8% to $6.29 after dropping 11% on Wednesday. The company recently reported 2021 sales of $4.20 million versus $6.57 million year over year.
PDS Biotechnology Corporation (NASDAQ:PDSB) rose 18.3% to $6.79 after the company announced the publication of an abstract by the American Society of Clinical Oncology summarizing interim data from the National Cancer Institute (NCI)-led Phase 2 trial evaluating a combination of PDS0101, M9241, and bintrafusp alfa in patients with HPV 16+ relapsed or refractory advanced cancer.
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) gained 18.3% to $19.31. Iovance Biotherapeutics recently provided a regulatory update for lifileucel potency assays. Following the update, the company CEO resigned.
Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) rose 16.7% to $11.35. Sensei Biotherapeutics revealed new data from the ongoing Phase 1/2 clinical trial of SNS-301 in patients with advanced squamous cell carcinoma of the head and neck (SCCHN), in combination with pembrolizumab.
F-star Therapeutics, Inc. (NASDAQ:FSTX) gained 15.2% to $7.98. HC Wainwright & Co. recently initiated coverage on the stock with a Buy rating and a price target of $35 per share.
Immutep Limited (NASDAQ:IMMP) rose 14.2% to $4.69 after the company announced the publication of TACTI-002 and INSIGHT-004 abstracts for ASCO 2021 Annual Meeting.
Nam Tai Property Inc. (NYSE:NTP) surged 14.1% to $22.91.
Youdao, Inc. (NYSE:DAO) shares jumped 14% to $25.54 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and announced a price target of $30 per share.
Summit Wireless Technologies, Inc. (NASDAQ:WISA) gained 13.6% to $4.625. The company, last week, released quarterly results.
Lightspeed POS Inc. (NYSE:LSPD) jumped 13% to $64.88 after reporting Q4 results.
Genetron Holdings Limited (NASDAQ:GTH) gained 12.7% to $21.89 after the company reported a strategic partnership with JD Health to create innovative solutions for full-cycle cancer management.
VistaGen Therapeutics, Inc (NASDAQ:VTGN) shares rose 12.2% to $2.5801. Baird initiated coverage on the stock with an Outperform rating and a $9 price target.
Vera Therapeutics, Inc. (NASDAQ:VERA) jumped 11.6% to $17.13. Vera Therapeutics, last week, priced its 4.35 million share IPO at $11 per share, well below its targeted range of $14 to $16, raising $47.58 million in gross proceeds.
MoSys, Inc. (NASDAQ:MOSY) gained 9.5% to $5.98 after jumping 44% on Wednesday.
Adaptimmune Therapeutics plc (NASDAQ:ADAP)shares rose 9.5% to $5.36 after the company revealed initial data from its Phase 2 SPEARHEAD-1 trial evaluating afamitresgene autoleucel (afami-cel, formerly ADP-A2M4).
SG Blocks, Inc. (NASDAQ:SGBX) shares rose 9% to $3.3683 after the company issued strong sales guidance for the first quarter.
DarioHealth Corp. (NASDAQ:DRIO) gained 7.8% to $16.82. DarioHealth recently reported a Q1 net loss of $15 million and agreed to acquire PsyInnovations Inc (dba wayForward), a behavioral health digital platform, for $30 million.
Super League Gaming, Inc. (NASDAQ:SLGG) rose 7.1% to $4.67. Super League Gaming recently reported a Q1 loss of $0.21 per share.
Advaxis, Inc. (NASDAQ:ADXS) shares rose 6% to $0.6098 after the company announced updated data from its Phase 1/2 study evaluating ADXS-503 in combination with Merck & Co Inc's Keytruda (pembrolizumab) in patients with metastatic non-small-cell lung cancer (NSCLC)..
PolarityTE, Inc. (NASDAQ:PTE) rose 5.7% to $1.0350 after a Form4 filing showed insider Peter A Cohen bought 265,000 shares of common stock at $0.98 per share for a total cost of $259,382.
ObsEva SA (NASDAQ:OBSV) rose 5% to $2.97 after the company announced final 76-week results from the PRIMROSE 1 Phase 3 clinical study evaluating Yselty (linzagolix) for heavy menstrual bleeding due to uterine fibroids.

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) shares dipped 30.3% to $15.49 after the company reported initial data from the Phase 1 dose-escalation portion of the Phase 1/2 MasterKey-01 trial evaluating BDTX-189 in patients with advanced solid tumors.
Merus N.V. (NASDAQ:MRUS) shares declined 16.7% to $21.00. Merus reported publication of abstract on Zenocutuzumab in NRG1-fusion (NRG1+) cancers at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting.
Aerpio Pharmaceuticals, Inc. (NASDAQ:ARPO) dropped 15.8% to $1.8699. The company issued an update on Aadi Bioscience presentation at the ASCO 2021 virtual meeting.
Omeros Corporation (NASDAQ:OMER) tumbled 13% to $14.77 after the company revealed that the FDA needs additional time to review narsoplimab marketing application for hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA).
Lordstown Motors Corp. (NASDAQ:RIDE) fell 12.6% to $10.01 after Wolfe Research downgraded the stock from Peer Perform to Underperform and lowered its price target from $18 to $1.
Kohl's Corporation (NYSE:KSS) dropped 12.3% to $52.85 despite the company better-than-expected Q1 results and raised FY21 outlook.
Triumph Group, Inc. (NYSE:TGI) fell 11.7% to $14.53 following Q4 results.
HOOKIPA Pharma Inc. (NASDAQ:HOOK) fell 11.4% to $16.86. HOOKIPA will present Phase 1 safety, tolerability and preliminary anti-tumor activity data on Hb-201 And Hb-202 for the treatment of advanced Hpv16+ cancers at the ASCO.
Fossil Group, Inc. (NASDAQ:FOSL) dipped 10.7% to $11.83.
Barnwell Industries, Inc. (NYSE:BRN) fell 9.6% to $2.645. The company, last week, reported quarterly results.
Ralph Lauren Corporation (NYSE:RL) dropped 9% to $119.22. Ralph Lauren swung to a profit in the fourth quarter.
Abercrombie & Fitch Co. (NYSE:ANF) fell 7.7% to $37.42.
FutureFuel Corp. (NYSE:FF) shares fell 6.6% to $12.55. FutureFuel, earlier during the month, reported Q1 results.
Wunong Net Technology Company Limited (NASDAQ:WNW) fell 6.5% to $6.97 after the company received notice of non-compliance with Nasdaq related to delayed filing of Form 20-F for FY20 period.